GeniPhys

GeniPhys is developing and commercializing its patented Collymer™ technology platform: a first-in-class polymerizable (scaffold-forming) collagen that supports custom design and fabrication of collagen materials for accelerated and improved tissue restoration and regeneration.

GeniPhys is a company in medtech based in Warsaw, IN.

Profile

"GeniPhys is a groundbreaking lifetech and medtech company focused on developing and commercializing the innovative Collymer™ technology platform. Collymer™ is a unique polymerizable collagen protein designed for in situ scaffold formation, offering a novel approach to tissue restoration and regeneration. This proprietary biopolymer, free of cellular or immunogenic components, minimizes adverse reactions commonly associated with traditional collagen therapies. GeniPhys's biofabrication techniques allow for customizable formats, including self-assembling scaffolds, sheets, tubes, and gradient-density materials tailored for various applications. Preclinical studies have shown promising results in supporting cellularization, vascularization, and innervation, essential for regenerative healing in wound care, breast reconstruction, and vocal fold repair. With significant NSF SBIR funding and FDA 510(k) clearance for advanced wound management, GeniPhys is poised to revolutionize regenerative medicine across multiple fields."

As a business in medtech, GeniPhys is listed here with the public details available about it.

Warsaw, IN is where the company is located.

The company is listed at the Plug and Play accelerated startup stage of development.

Website: www.geniphys.com